Newgen Life Sciences Private Limited
About Newgen Life Sciences Private Limited
Data last updated:
Newgen Life Sciences Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 January 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51397TN2008PTC066265. Its GSTIN is 33AADCN2045A1Z8 (Tamil Nadu).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Thirunavukkarasu Elango and Subbiah Kuthalingam Ramasubramanian.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.7/11 Bharathi Nagar 2nd Street T.Nagar, Chennai, Tamil Nadu, India – 600017.
As per the financials filed for FY 2024, the company reported a revenue of ₹35.01 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.84 Lakh (net margin 5.3%) and EBITDA of ₹2.54 Lakh (EBITDA margin 7.3%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 13% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Newgen Life Sciences Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo.7/11 Bharathi Nagar 2nd Street T.Nagar, Chennai, Tamil Nadu, India – 600017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Newgen Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Newgen Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Newgen Life Sciences Private Limited, buy the company report.
Financials of Newgen Life Sciences Private Limited
FY 2025 filings availableNewgen Life Sciences Private Limited reported revenue of ₹35.01 Lakh (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 6% fall in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Newgen Life Sciences Private Limited, buy the company report.
Board of directors of Newgen Life Sciences Private Limited
Newgen Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thirunavukkarasu Elango | Director | 31 Jan 2008 | 18 Years 9 Months | Current |
| Subbiah Kuthalingam Ramasubramanian Also directs: Bioceuticsinc India Private Limited | Director | 31 Jan 2008 | 18 Years 9 Months | Current |
Shareholding
The shareholding of Newgen Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Newgen Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Newgen Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Newgen Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Newgen Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCN2045A1Z8 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Newgen Life Sciences Private Limited, buy the company report.
Recent activity
Newgen Life Sciences Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Subbiah Kuthalingam Ramasubramanian was appointed as Director on 31 Jan 2008.
Frequently asked questions
Newgen Life Sciences is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 January 2008 (18+ years old) and is registered under CIN U51397TN2008PTC066265.
Newgen Life Sciences has 2 current directors:
- Thirunavukkarasu Elango - Director
- Subbiah Kuthalingam Ramasubramanian - Director
The latest financial statements of Newgen Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Newgen Life Sciences is 33AADCN2045A1Z8, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Newgen Life Sciences is U51397TN2008PTC066265. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Newgen Life Sciences was incorporated on 31 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chennai.
Subbiah Kuthalingam Ramasubramanian was appointed as Director on 31 Jan 2008. Thirunavukkarasu Elango was appointed as Director on 31 Jan 2008.
The registered office of Newgen Life Sciences is at No.711 Bharathi Nagar 2nd Street T.Nagar, Chennai, Tamil Nadu, India – 600017.
Newgen Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Newgen Life Sciences is active non-compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
